GlobalData on MSN10h
Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback